CYTOKINETICS, INCORPORATED Total Long-Term Debt
CYTOKINETICS, INCORPORATED (CYTK) had Total Long-Term Debt of $1.00 billion as of 2025-09-30, per its 10-Q filed 2025-11-05.
Financial Statements › Balance Sheet › Liabilities › Debt
us-gaap:LongTermDebt · last filed 2025-11-05
- 2025-09-30: Long-term Debt $1.00B.
- 2025-06-30: Long-term Debt $609.65M.
- 2025-03-31: Long-term Debt $610.07M.
- 2024-12-31: Long-term Debt $619.52M.
| Period end | Long-term Debt |
|---|---|
| 2025-09-30 | $1.00B 10-Q · filed 2025-11-05 |
| 2025-06-30 | $609.65M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $610.07M 10-Q · filed 2025-05-06 |
| 2024-12-31 | $619.52M 10-K · filed 2025-02-27 |
| 2024-09-30 | $619.95M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $629.40M 10-Q · filed 2024-08-09 |
| 2024-03-31 | $629.82M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $639.27M 10-K · filed 2024-02-28 |
| 2022-12-31 | $649.56M 10-K · filed 2023-03-01 |
| 2019-03-31 | $42.59M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $42.41M 10-Q · filed 2019-05-09 |
| 2018-09-30 | $41.91M 10-Q · filed 2018-11-09 |
| 2018-06-30 | $32.37M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $31.95M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $31.78M 10-K · filed 2019-03-07 |
| 2017-09-30 | $30.30M 10-Q · filed 2017-11-03 |
| 2017-06-30 | $30.16M 10-Q · filed 2017-08-04 |
| 2017-03-31 | $30.02M 10-Q · filed 2017-05-04 |
| 2016-12-31 | $29.88M 10-K · filed 2018-03-05 |
| 2015-12-31 | $14.64M 10-K · filed 2017-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |